QHSLab USAQ Stock
QHSLab Price Chart
QHSLab USAQ Financial and Trading Overview
| QHSLab stock price | 0.57 USD |
| Previous Close | 0.57 USD |
| Open | 0.5 USD |
| Bid | 0.34 USD x 954900 |
| Ask | 0.52 USD x 100000 |
| Day's Range | 0.34 - 0.5 USD |
| 52 Week Range | 0.08 - 1.14 USD |
| Volume | 2.95K USD |
| Avg. Volume | 2.42K USD |
| Market Cap | 8.51M USD |
| Beta (5Y Monthly) | 0.485 |
| PE Ratio (TTM) | 18.866667 |
| EPS (TTM) | 0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
USAQ Valuation Measures
| Enterprise Value | 8.27M USD |
| Trailing P/E | 18.866667 |
| Forward P/E | 11.32 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0661392 |
| Price/Book (mrq) | 5.60396 |
| Enterprise Value/Revenue | 2.98 |
| Enterprise Value/EBITDA | 68.341 |
Trading Information
QHSLab Stock Price History
| Beta (5Y Monthly) | 0.485 |
| 52-Week Change | 232.94% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.14 USD |
| 52 Week Low | 0.08 USD |
| 50-Day Moving Average | 0.6 USD |
| 200-Day Moving Average | 0.45 USD |
USAQ Share Statistics
| Avg. Volume (3 month) | 2.42K USD |
| Avg. Daily Volume (10-Days) | 820 USD |
| Shares Outstanding | 15.03M |
| Float | 6.37M |
| Short Ratio | N/A |
| % Held by Insiders | 48.72% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 15.60% |
| Operating Margin (ttm) | -12.95% |
| Gross Margin | 66.72% |
| EBITDA Margin | 4.36% |
Management Effectiveness
| Return on Assets (ttm) | 1.71% |
| Return on Equity (ttm) | 93.17% |
Income Statement
| Revenue (ttm) | 2.78M USD |
| Revenue Per Share (ttm) | 0.23 USD |
| Quarterly Revenue Growth (yoy) | 12.90% |
| Gross Profit (ttm) | 1.85M USD |
| EBITDA | 121.02K USD |
| Net Income Avi to Common (ttm) | 433.12K USD |
| Diluted EPS (ttm) | 0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 362.09K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 130.18K USD |
| Total Debt/Equity (mrq) | 8.56 USD |
| Current Ratio (mrq) | 1.682 |
| Book Value Per Share (mrq) | 0.101 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 27.43K USD |
| Levered Free Cash Flow (ttm) | -402903 USD |
Profile of QHSLab
| Country | United States |
| State | FL |
| City | West Palm Beach |
| Address | 901 Northpoint Parkway |
| ZIP | 33407 |
| Phone | 929 379 6503 |
| Website | https://www.qhslab.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health system lab expert system (QHSLab), designed to function as an extension of a medical practice's existing clinical workflow that supports structured screening, automated documentation, and digital follow-up while minimizing disruption to physicians and staff; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.
Q&A For QHSLab Stock
What is a current USAQ stock price?
QHSLab USAQ stock price today per share is 0.57 USD.
How to purchase QHSLab stock?
You can buy USAQ shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for QHSLab?
The stock symbol or ticker of QHSLab is USAQ.
Which industry does the QHSLab company belong to?
The QHSLab industry is Medical Devices.
How many shares does QHSLab have in circulation?
The max supply of QHSLab shares is 15.03M.
What is QHSLab Price to Earnings Ratio (PE Ratio)?
QHSLab PE Ratio is 18.86666700 now.
What was QHSLab earnings per share over the trailing 12 months (TTM)?
QHSLab EPS is 0.03 USD over the trailing 12 months.
Which sector does the QHSLab company belong to?
The QHSLab sector is Healthcare.